1. Home
  2. CNXN vs IMCR Comparison

CNXN vs IMCR Comparison

Compare CNXN & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CNXN

PC Connection Inc.

HOLD

Current Price

$66.89

Market Cap

1.6B

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$29.73

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNXN
IMCR
Founded
1982
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
1997
2016

Fundamental Metrics

Financial Performance
Metric
CNXN
IMCR
Price
$66.89
$29.73
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$66.33
AVG Volume (30 Days)
48.8K
366.2K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
1.26%
N/A
EPS Growth
N/A
30.39
EPS
0.68
0.25
Revenue
N/A
$249,428,000.00
Revenue This Year
$6.24
$14.57
Revenue Next Year
$4.39
$8.21
P/E Ratio
$96.28
$122.22
Revenue Growth
N/A
43.05
52 Week Low
$54.97
$27.47
52 Week High
$71.17
$40.71

Technical Indicators

Market Signals
Indicator
CNXN
IMCR
Relative Strength Index (RSI) 68.18 47.99
Support Level $56.14 $28.23
Resistance Level $66.89 $34.35
Average True Range (ATR) 1.70 1.35
MACD 0.08 0.16
Stochastic Oscillator 87.35 53.87

Price Performance

Historical Comparison
CNXN
IMCR

About CNXN PC Connection Inc.

PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: